# Official Journal C 102/28 A

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 102 |
| | |
| English edition | Information and Notices | Volume 4928 April 2006 |

ISSN 1725-2423

Official Journal

of the European Union

C 102

English edition

Information and Notices

Volume 4928 April 2006

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Commission |
| 2006/C 102/1 | Euro exchange rates | 1 |
| 2006/C 102/2 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.3.2006 to 31.3.2006(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) | 2 |
| 2006/C 102/3 | Prior notification of a concentration (Case COMP/M.4218 — Investcorp/Orefi Participation) — Candidate case for simplified procedure (
  1
  ) | 8 |
| 2006/C 102/4 | Prior notification of a concentration (Case COMP/M.4071 — Apollo/Akzo Nobel IAR) (
  1
  ) | 9 |
| 2006/C 102/5 | Prior notification of a concentration (Case COMP/M.4193 — L'Oréal/The Body Shop) (
  1
  ) | 10 |
| 2006/C 102/6 | Non-opposition to a notified concentration (Case COMP/M.4155 — BNP Paribas/BNL) (
  1
  ) | 11 |
| 2006/C 102/7 | Non-opposition to a notified concentration (Case COMP/M.4161 — SEI/VWBN) (
  1
  ) | 11 |
| 2006/C 102/8 | Non-opposition to a notified concentration (Case COMP/M.4085 — Arcelor/OYAK/Erdemir) (
  1
  ) | 12 |
| 2006/C 102/9 | Non-opposition to a notified concentration (Case COMP/M.4190 — Autostrade/SIAS/Costanera) (
  1
  ) | 12 |

Notice No

Contents

page

I   Information

Commission

2006/C 102/1

Euro exchange rates

1

2006/C 102/2

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.3.2006 to 31.3.2006(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

2

2006/C 102/3

Prior notification of a concentration (Case COMP/M.4218 — Investcorp/Orefi Participation) — Candidate case for simplified procedure (
  1
  )

1

8

2006/C 102/4

Prior notification of a concentration (Case COMP/M.4071 — Apollo/Akzo Nobel IAR) (
  1
  )

1

9

2006/C 102/5

Prior notification of a concentration (Case COMP/M.4193 — L'Oréal/The Body Shop) (
  1
  )

1

10

2006/C 102/6

Non-opposition to a notified concentration (Case COMP/M.4155 — BNP Paribas/BNL) (
  1
  )

1

11

2006/C 102/7

Non-opposition to a notified concentration (Case COMP/M.4161 — SEI/VWBN) (
  1
  )

1

11

2006/C 102/8

Non-opposition to a notified concentration (Case COMP/M.4085 — Arcelor/OYAK/Erdemir) (
  1
  )

1

12

2006/C 102/9

Non-opposition to a notified concentration (Case COMP/M.4190 — Autostrade/SIAS/Costanera) (
  1
  )

1

12

| | III   Notices |
| --- | --- |
| | Commission |
| 2006/C 102/0 | Call for proposals 2006 — Specific projects in the field of consumer affairs | 13 |
| 2006/C 102/1 | Second call for proposals for the community programme on the conservation, characterisation, collection and utilisation of genetic resources in agriculture established by Council Regulation (EC) No 870/2004 of 24 April 2004 — Call identifier: AGRI GEN RES 2006 | 15 |

III   Notices

Commission

2006/C 102/0

Call for proposals 2006 — Specific projects in the field of consumer affairs

13

2006/C 102/1

Second call for proposals for the community programme on the conservation, characterisation, collection and utilisation of genetic resources in agriculture established by Council Regulation (EC) No 870/2004 of 24 April 2004 — Call identifier: AGRI GEN RES 2006

15

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

I Information

Commission

| 28.4.2006 | EN | Official Journal of the European Union | C 102/1 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/1

---

Euro exchange rates (1)

27 April 2006

(2006/C 102/01)

1 euro=

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2414 |
| JPY | Japanese yen | 142,71 |
| DKK | Danish krone | 7,4602 |
| GBP | Pound sterling | 0,6958 |
| SEK | Swedish krona | 9,3328 |
| CHF | Swiss franc | 1,5814 |
| ISK | Iceland króna | 93,03 |
| NOK | Norwegian krone | 7,796 |
| BGN | Bulgarian lev | 1,9558 |
| CYP | Cyprus pound | 0,5761 |
| CZK | Czech koruna | 28,445 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 265,38 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6961 |
| MTL | Maltese lira | 0,4293 |
| PLN | Polish zloty | 3,8737 |
| RON | Romanian leu | 3,475 |
| SIT | Slovenian tolar | 239,58 |
| SKK | Slovak koruna | 37,395 |
| TRY | Turkish lira | 1,648 |
| AUD | Australian dollar | 1,6546 |
| CAD | Canadian dollar | 1,4043 |
| HKD | Hong Kong dollar | 9,6267 |
| NZD | New Zealand dollar | 1,9751 |
| SGD | Singapore dollar | 1,9702 |
| KRW | South Korean won | 1 173 |
| ZAR | South African rand | 7,6833 |
| CNY | Chinese yuan renminbi | 9,9566 |
| HRK | Croatian kuna | 7,2901 |
| IDR | Indonesian rupiah | 10 928,04 |
| MYR | Malaysian ringgit | 4,5063 |
| PHP | Philippine peso | 64,218 |
| RUB | Russian rouble | 34,011 |
| THB | Thai baht | 46,717 |

Currency

Exchange rate

USD

US dollar

1,2414

JPY

Japanese yen

142,71

DKK

Danish krone

7,4602

GBP

Pound sterling

0,6958

SEK

Swedish krona

9,3328

CHF

Swiss franc

1,5814

ISK

Iceland króna

93,03

NOK

Norwegian krone

7,796

BGN

Bulgarian lev

1,9558

CYP

Cyprus pound

0,5761

CZK

Czech koruna

28,445

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

265,38

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6961

MTL

Maltese lira

0,4293

PLN

Polish zloty

3,8737

RON

Romanian leu

3,475

SIT

Slovenian tolar

239,58

SKK

Slovak koruna

37,395

TRY

Turkish lira

1,648

AUD

Australian dollar

1,6546

CAD

Canadian dollar

1,4043

HKD

Hong Kong dollar

9,6267

NZD

New Zealand dollar

1,9751

SGD

Singapore dollar

1,9702

KRW

South Korean won

1 173

ZAR

South African rand

7,6833

CNY

Chinese yuan renminbi

9,9566

HRK

Croatian kuna

7,2901

IDR

Indonesian rupiah

10 928,04

MYR

Malaysian ringgit

4,5063

PHP

Philippine peso

64,218

RUB

Russian rouble

34,011

THB

Thai baht

46,717

---

(1)

Source: reference exchange rate published by the ECB.

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/2 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/2

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.3.2006 to 31.3.2006

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))

(2006/C 102/02)

—   Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN
  (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code
  (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 29.3.2006 | Myozyme | alglucosidase alpha | Genzyme Europe B.V. |
| Gooimeer 10 |
| 1411 DD Naarden |
| Nederland |

Date of the decision

Name of the medicinal product

INN

(International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code

(Anatomical Therapeutic Chemical Code)

Date of notification

29.3.2006

Myozyme

alglucosidase alpha

Genzyme Europe B.V.

Gooimeer 10

1411 DD Naarden

Nederland

EU/1/06/333/001-003

Powder for concentrate for solution for infusion

A16AB07

31.3.2006

—   Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 2.3.2006 | Prometax | Novartis Europharm Limited |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

2.3.2006

Prometax

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/98/092/001-018

6.3.2006

8.3.2006

Litak

| Lipomed GmbH |
| --- |
| Schönaugasse 11 |
| D-79713 Bad Säckingen |

Lipomed GmbH

Schönaugasse 11

D-79713 Bad Säckingen

EU/1/04/275/001-002

10.3.2006

9.3.2006

Kentera

| Nicobrand Limited |
| --- |
| 189 Casteroe Road |
| Coleraine |
| Northern Ireland BT51 3 RP |

Nicobrand Limited

189 Casteroe Road

Coleraine

Northern Ireland BT51 3 RP

EU/1/03/270/001-003

13.3.2006

13.3.2006

Cellcept

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City |
| AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City

AL7 1TW

United Kingdom

EU/1/96/005/001-006

15.3.2006

13.3.2006

Enbrel

| Wyeth Europa Limited |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire |
| SL6 0PH |
| United Kingdom |

Wyeth Europa Limited

Huntercombe Lane South

Taplow

Maidenhead

Berkshire

SL6 0PH

United Kingdom

EU/1/99/126/001-011

15.3.2006

15.3.2006

Angiox

| The Medicines Company UK Ltd |
| --- |
| Suite B |
| Park House |
| 11 Milton Park |
| Abingdon |
| Oxfordshire OX14 4RS |
| United Kingdom |

The Medicines Company UK Ltd

Suite B

Park House

11 Milton Park

Abingdon

Oxfordshire OX14 4RS

United Kingdom

EU/1/04/289/001-002

17.3.2006

20.3.2006

CoAprovel

| Sanofi Pharma Bristol-Myers Squibb SNC |
| --- |
| 174, avenue de France |
| F-75013 Paris |

Sanofi Pharma Bristol-Myers Squibb SNC

174, avenue de France

F-75013 Paris

EU/1/98/086/001-022

22.3.2006

20.3.2006

Karvezide

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| 141-149 Staines Road |
| Hounslow TW3 3JA |
| United Kingdom |

Bristol-Myers Squibb Pharma EEIG

141-149 Staines Road

Hounslow TW3 3JA

United Kingdom

EU/1/98/085/001-022

22.3.2006

20.3.2006

Glivec

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/01/198/001-013

22.3.2006

20.3.2006

Zyprexa

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/96/022/016-017

22.3.2006

20.3.2006

Prialt

| Elan Pharma International Ltd |
| --- |
| WIL House |
| Shannon Business Park |
| Shannon |
| County Clare |
| Ireland |

Elan Pharma International Ltd

WIL House

Shannon Business Park

Shannon

County Clare

Ireland

EU/1/04/302/004

22.3.2006

20.3.2006

Lyrica

| PFIZER Ltd |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent CT 13 9NJ |
| United Kingdom |

PFIZER Ltd

Ramsgate Road

Sandwich

Kent CT 13 9NJ

United Kingdom

EU/1/04/279/001-032

22.3.2006

20.3.2006

Mabthera

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City |
| AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City

AL7 1TW

United Kingdom

EU/1/98/067/001-002

22.3.2006

21.3.2006

NutropinAq

| IPSEN Limited |
| --- |
| 190 Bath Road |
| Slough |
| Berkshire |
| SLI 3XE |
| United Kingdom |

IPSEN Limited

190 Bath Road

Slough

Berkshire

SLI 3XE

United Kingdom

EU/1/00/164/003-005

23.3.2006

21.3.2006

Exubera

| PFIZER Ltd |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent CT 13 9NJ |
| United Kingdom |

PFIZER Ltd

Ramsgate Road

Sandwich

Kent CT 13 9NJ

United Kingdom

| Aventis/Pfizer EEIG |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent CT13 9NJ |
| United Kingdom |

Aventis/Pfizer EEIG

Ramsgate Road

Sandwich

Kent CT13 9NJ

United Kingdom

EU/1/05/327/001-017

23.3.2006

22.3.2006

Kinzalmono

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

| Bayer AG |
| --- |
| D-51368 Leverkusen |

Bayer AG

D-51368 Leverkusen

EU/1/98/091/001-014

24.3.2006

22.3.2006

NeoSpect

| CIS bio international |
| --- |
| Route Nationale 306 |
| Saclay |
| Boite Postale 32 |
| F-91192 Gifsur-Yvette |

CIS bio international

Route Nationale 306

Saclay

Boite Postale 32

F-91192 Gifsur-Yvette

| Amersham Health AS |
| --- |
| Nycoveien 1-2 |
| P.O. Box 4220 Nydalen |
| N-0401 Oslo |

Amersham Health AS

Nycoveien 1-2

P.O. Box 4220 Nydalen

N-0401 Oslo

EU/1/00/154/001-002

24.3.2006

22.3.2006

Tarceva

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City |
| AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City

AL7 1TW

United Kingdom

EU/1/05/311/001-003

24.3.2006

22.3.2006

Kinzalkomb

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

| Bayer AG |
| --- |
| D-51368 Leverkusen |

Bayer AG

D-51368 Leverkusen

EU/1/02/214/001-010

24.3.2006

22.3.2006

Pritor

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

| Glaxo Group Ltd |
| --- |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/98/089/001-019

24.3.2006

22.3.2006

PritorPlus

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/02/215/001-012

24.3.2006

22.3.2006

Levviax

| Aventis Pharma S.A. |
| --- |
| 20, Avenue Raymond Aron |
| F-92160 Antony |

Aventis Pharma S.A.

20, Avenue Raymond Aron

F-92160 Antony

EU/1/01/192/001-005

24.3.2006

22.3.2006

Ketek

| Aventis Pharma S.A. |
| --- |
| 20, Avenue Raymond Aron |
| F-92160 Antony |

Aventis Pharma S.A.

20, Avenue Raymond Aron

F-92160 Antony

EU/1/01/191/001-005

24.3.2006

22.3.2006

Avonex

| Biogen Idec Ltd |
| --- |
| 5 Roxborough Way |
| Foundation Park |
| Maidenhead |
| Berkshire |
| SL6 3UD |
| United Kingdom |

Biogen Idec Ltd

5 Roxborough Way

Foundation Park

Maidenhead

Berkshire

SL6 3UD

United Kingdom

EU/1/97/033/001-003

24.3.2006

23.3.2006

Cancidas

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/01/196/001-003

28.3.2006

29.3.2006

Actos

| Takeda Europe R&D Centre Ltd |
| --- |
| Arundel Great Court |
| 2 Arundel Street |
| London WC2R 3DA |
| United Kingdom |

Takeda Europe R&D Centre Ltd

Arundel Great Court

2 Arundel Street

London WC2R 3DA

United Kingdom

EU/1/00/150/001-024

31.3.2006

29.3.2006

IntronA

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73/Stallestraat, 73 |
| B-1180 Bruxelles/Brussel |

Schering Plough Europe

Rue de Stalle, 73/Stallestraat, 73

B-1180 Bruxelles/Brussel

EU/1/99/127/001-044

31.3.2006

29.3.2006

Parareg

| Dompé Biotec S.p.A. |
| --- |
| Via San Martino, 12 |
| I-20122 Milano |

Dompé Biotec S.p.A.

Via San Martino, 12

I-20122 Milano

EU/1/04/293/001-012

31.3.2006

29.3.2006

Mimpara

| Amgen Europe B.V. |
| --- |
| Minervum 7061 |
| 4817 ZK Breda |
| Nederland |

Amgen Europe B.V.

Minervum 7061

4817 ZK Breda

Nederland

EU/1/04/292/001-012

31.3.2006

29.3.2006

Viraferon

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73/Stallestraat, 73 |
| B-1180 Bruxelles/Brussel |

Schering Plough Europe

Rue de Stalle, 73/Stallestraat, 73

B-1180 Bruxelles/Brussel

EU/1/99/128/001-037

31.3.2006

29.3.2006

Glustin

| Takeda Europe R&D Centre Ltd |
| --- |
| Arundel Great Court |
| 2 Arundel Street |
| London WC2R 3DA |
| United Kingdom |

Takeda Europe R&D Centre Ltd

Arundel Great Court

2 Arundel Street

London WC2R 3DA

United Kingdom

EU/1/00/151/001-022

31.3.2006

29.3.2006

Ariclaim

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/04/283/001-007

31.3.2006

29.3.2006

Raptiva

| Serono Europe Limited |
| --- |
| 56, Marsh Wall |
| London E14 9TP |
| United Kingdom |

Serono Europe Limited

56, Marsh Wall

London E14 9TP

United Kingdom

EU/1/04/291/001-002

5.4.2006

29.3.2006

Hepsera

| Gilead Sciences International Limited |
| --- |
| Cambridge CB1 6GT |
| United Kingdom |

Gilead Sciences International Limited

Cambridge CB1 6GT

United Kingdom

EU/1/03/251/001

31.3.2006

29.3.2006

Erbitux

| Merck KGaA |
| --- |
| Frankfurter Straße 250 |
| D-64293 Darmstadt |

Merck KGaA

Frankfurter Straße 250

D-64293 Darmstadt

EU/1/04/281/001

31.3.2006

29.3.2006

Keppra

| UCB S.A. |
| --- |
| Allée de la recherche, 60/Researchdreef, 60 |
| B-1070 Bruxelles/Brussel |

UCB S.A.

Allée de la recherche, 60/Researchdreef, 60

B-1070 Bruxelles/Brussel

EU/1/00/146/030

31.3.2006

29.3.2006

Rebetol

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73/Stallestraat, 73 |
| B-1180 Bruxelles/Brussel |

Schering Plough Europe

Rue de Stalle, 73/Stallestraat, 73

B-1180 Bruxelles/Brussel

EU/1/99/107/001-005

30.3.2006

29.3.2006

Protopy

| Astellas Pharma GmbH |
| --- |
| Neumarkter Str. 61 |
| D-81673 München |

Astellas Pharma GmbH

Neumarkter Str. 61

D-81673 München

EU/1/02/202/001-006

31.3.2006

29.3.2006

Protopic

| Astellas Pharma GmbH |
| --- |
| Neumarkter Str. 61 |
| D-81673 München |

Astellas Pharma GmbH

Neumarkter Str. 61

D-81673 München

EU/1/02/201/001-006

31.3.2006

29.3.2006

Aptivus

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/05/315/001

31.3.2006

29.3.2006

Bondenza

| Roche Registration Limited |
| --- |
| 6 Falcon Way Shire Park |
| Welwyn Garden City |
| Hertfordshire AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way Shire Park

Welwyn Garden City

Hertfordshire AL7 1TW

United Kingdom

EU/1/03/266/005-006

31.3.2006

29.3.2006

Xeristar

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/04/297/001-007

31.3.2006

29.3.2006

YENTREVE

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/04/280/001-007

31.3.2006

29.3.2006

Prialt

| Elan Pharma International Ltd |
| --- |
| WIL House |
| Shannon Business Park |
| Shannon |
| County Clare |
| Ireland |

Elan Pharma International Ltd

WIL House

Shannon Business Park

Shannon

County Clare

Ireland

EU/1/04/302/001-004

3.4.2006

29.3.2006

NovoMix

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/00/142/004-005

EU/1/00/142/009-022

31.3.2006

29.3.2006

Cymbalta

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/04/296/001-007

31.3.2006

29.3.2006

Pedea

| Orphan Europe |
| --- |
| Immeuble «Le Guillaumet» |
| F-92046 Paris La Défense |

Orphan Europe

Immeuble «Le Guillaumet»

F-92046 Paris La Défense

EU/1/04/284/001

31.3.2006

29.3.2006

Bonviva

| Roche Registration Limited |
| --- |
| 6 Falcon Way Shire Park |
| Welwyn Garden City |
| Hertfordshire AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way Shire Park

Welwyn Garden City

Hertfordshire AL7 1TW

United Kingdom

EU/1/03/265/005-006

31.3.2006

29.3.2006

NovoRapid

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/99/119/001

EU/1/99/119/003

EU/1/99/119/005-014

31.3.2006

29.3.2006

InductOs

| Wyeth Europa Ltd. |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire |
| SL6 0PH |
| United Kingdom |

Wyeth Europa Ltd.

Huntercombe Lane South

Taplow

Maidenhead

Berkshire

SL6 0PH

United Kingdom

EU/1/02/226/001

31.3.2006

29.3.2006

Truvada

| Gilead Sciences International Limited |
| --- |
| Granta Park |
| Abington Cambridge CB1 6GT |
| United Kingdom |

Gilead Sciences International Limited

Granta Park

Abington Cambridge CB1 6GT

United Kingdom

EU/1/04/305/001

31.3.2006

—   Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 15.3.2006 | Zubrin | Schering Plough Limited |
| Schering Plough House |
| Shire Park |
| Welwyn Garden City |
| Hertfordshire |
| AL7 1TW |
| United Kingdom |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

15.3.2006

Zubrin

Schering Plough Limited

Schering Plough House

Shire Park

Welwyn Garden City

Hertfordshire

AL7 1TW

United Kingdom

EU/2/00/028/002-008

17.3.2006

21.3.2006

Porcilis Pesti

| Intervet International B.V. |
| --- |
| Wim de Körverstraat 35 |
| 5831 AN Boxmeer |
| Nederland |

Intervet International B.V.

Wim de Körverstraat 35

5831 AN Boxmeer

Nederland

EU/2/99/016/001-006

23.3.2006

23.3.2006

METACAM

| Boehringer Ingelheim Vetmedica GmbH |
| --- |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein

EU/2/97/004/016-023

28.3.2006

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| The European Medicines Agency |
| --- |
| 7, Westferry Circus, Canary Wharf |
| London E14 4HB |
| United Kingdom |

The European Medicines Agency

7, Westferry Circus, Canary Wharf

London E14 4HB

United Kingdom

---

(1)  OJ L 136, 30.4.2004, p. 1.

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/8 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/8

---

Prior notification of a concentration

(Case COMP/M.4218 — Investcorp/Orefi Participation)

Candidate case for simplified procedure

(2006/C 102/03)

(Text with EEA relevance)

| 1. | On 20 April 2006 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the Investcorp Group (‘Investcorp’, UK) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of Orefi Participation (‘Orefi’, France), by way of purchase of shares. |
| --- | --- |

1.

On 20 April 2006 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the Investcorp Group (‘Investcorp’, UK) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of Orefi Participation (‘Orefi’, France), by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | Investcorp: international financial institution acting as a principal and as an intermediary in international investment transactions; |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

Investcorp: international financial institution acting as a principal and as an intermediary in international investment transactions;

| — | Orefi: purchase and distribution of industrial parts, for the mechanical transmission, automation, assembling, tooling, and other sectors. |
| --- | --- |

—

Orefi: purchase and distribution of industrial parts, for the mechanical transmission, automation, assembling, tooling, and other sectors.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4218 — Investcorp/Orefi Participation, to the following address:





  European Commission |
| --- | --- |
| Competition DG |
| Merger Registry |
| J-70 |
| B-1049 Brussels |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4218 — Investcorp/Orefi Participation, to the following address:

European Commission

Competition DG

Merger Registry

J-70

B-1049 Brussels

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  OJ C 56, 5.3.2005, p. 32.

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/9 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/9

---

Prior notification of a concentration

(Case COMP/M.4071 — Apollo/Akzo Nobel IAR)

(2006/C 102/04)

(Text with EEA relevance)

| 1. | On 18 April 2006, the Commission received a notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) by which the undertaking Hexion Speciality Chemicals (‘Hexion’, USA), belonging to the Apollo Group (‘Apollo Group’, USA), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of Akzo Nobel's Inks and Adhesive Resins business (‘IAR’, the Netherlands) by way of purchase of shares and assets. |
| --- | --- |

1.

On 18 April 2006, the Commission received a notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) by which the undertaking Hexion Speciality Chemicals (‘Hexion’, USA), belonging to the Apollo Group (‘Apollo Group’, USA), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of Akzo Nobel's Inks and Adhesive Resins business (‘IAR’, the Netherlands) by way of purchase of shares and assets.

| 2. | The business activities of the undertakings concerned are:






  — | for Apollo Group: portfolio investments; |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Apollo Group: portfolio investments;

| — | for Hexion: thermosetting resins and other speciality chemicals; |
| --- | --- |

—

for Hexion: thermosetting resins and other speciality chemicals;

| — | for IAR: rosin resins and related chemicals for ink and other applications. |
| --- | --- |

—

for IAR: rosin resins and related chemicals for ink and other applications.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4071 — Apollo/Akzo Nobel IAR, to the following address:





  European Commission |
| --- | --- |
| Competition DG |
| Merger Registry |
| J-70 |
| B-1049 Brussels |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4071 — Apollo/Akzo Nobel IAR, to the following address:

European Commission

Competition DG

Merger Registry

J-70

B-1049 Brussels

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/10 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/10

---

Prior notification of a concentration

(Case COMP/M.4193 — L'Oréal/The Body Shop)

(2006/C 102/05)

(Text with EEA relevance)

| 1. | On 20 April 2006, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking L'Oréal SA (‘L'Oréal’, France) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking The Body Shop International plc (‘The Body Shop’, United Kingdom) by way of purchase of shares. |
| --- | --- |

1.

On 20 April 2006, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking L'Oréal SA (‘L'Oréal’, France) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking The Body Shop International plc (‘The Body Shop’, United Kingdom) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for L'Oréal: research, development, manufacturing, marketing, distribution and sale of cosmetics products; |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for L'Oréal: research, development, manufacturing, marketing, distribution and sale of cosmetics products;

| — | for The Body Shop: marketing, distribution and sale of cosmetics products through a network of single-brand The Body Shop stores. |
| --- | --- |

—

for The Body Shop: marketing, distribution and sale of cosmetics products through a network of single-brand The Body Shop stores.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4193 — L'Oréal/The Body Shop, to the following address:





  European Commission |
| --- | --- |
| Competition DG |
| Merger Registry |
| J-70 |
| B-1049 Brussels |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4193 — L'Oréal/The Body Shop, to the following address:

European Commission

Competition DG

Merger Registry

J-70

B-1049 Brussels

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/11 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/11

---

Non-opposition to a notified concentration

(Case COMP/M.4155 — BNP Paribas/BNL)

(2006/C 102/06)

(Text with EEA relevance)

On 28 March 2006, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://europa.eu.int/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://europa.eu.int/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32006M4155. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32006M4155. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/11 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/11

---

Non-opposition to a notified concentration

(Case COMP/M.4161 — SEI/VWBN)

(2006/C 102/07)

(Text with EEA relevance)

On 30 March 2006, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://europa.eu.int/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://europa.eu.int/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32006M4161. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32006M4161. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/12 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/12

---

Non-opposition to a notified concentration

(Case COMP/M.4085 — Arcelor/OYAK/Erdemir)

(2006/C 102/08)

(Text with EEA relevance)

On 13 February 2006, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://europa.eu.int/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://europa.eu.int/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32006M4085. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32006M4085. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/12 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/12

---

Non-opposition to a notified concentration

(Case COMP/M.4190 — Autostrade/SIAS/Costanera)

(2006/C 102/09)

(Text with EEA relevance)

On 18 April 2006, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://europa.eu.int/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://europa.eu.int/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32006M4190. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32006M4190. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---

III Notices

Commission

| 28.4.2006 | EN | Official Journal of the European Union | C 102/13 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/13

---

CALL FOR PROPOSALS 2006

Specific projects in the field of consumer affairs

(2006/C 102/10)

1.   Objectives and description

This call for proposals for specific projects relates to the implementation of Article 7(4) (action 18) of Decision No 20/2004/EC of the European Parliament and of the Council of 8 December 2003 establishing a general framework for financing Community actions in support of consumer policy for the years 2004 to 2007. This call is foreseen, and the budget allocation is set, in point 4.2 and annex 1 of the 2006 annual work programme in the area of consumer policy.

Projects must contribute significantly to the achievement of the European consumer policy, of which objectives are defined in the Decision No 20/2004/EC and in the Commission's Consumer Policy Strategy for 2002-2006 (1).

2.   Eligible applicants

For project proposals seeking a maximum of 50 % Community funding: financial contributions for projects may be awarded to any legal person or association of legal persons, including appropriate independent public bodies and regional consumer organisations, that act independently of industry and commerce and are actually responsible for the implementation of the projects. In addition to the applicant organisation, proposals must involve as partners at least 8 consumer organisations from different countries, 3 of which must be registered in the new Member States or Acceding countries.

For project proposals seeking a maximum of 75 % Community funding: financial contributions may only be awarded to projects proposed by consumer organisations registered in the new Member States or acceding countries, that act independently of industry and commerce and are actually responsible for the implementation of the projects. They must involve as partners at least 3 consumer organisations registered in any of the countries eligible for this call.

Applicants must be established in one of the following countries:

| — | the 25 countries of the European Union, of which the ‘new Member States’ are: Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Slovak Republic and Slovenia. |
| --- | --- |

—

the 25 countries of the European Union, of which the ‘new Member States’ are: Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Slovak Republic and Slovenia.

| — | the European Economic Area countries: Iceland, Liechtenstein, Norway |
| --- | --- |

—

the European Economic Area countries: Iceland, Liechtenstein, Norway

| — | the acceding countries: Bulgaria and Romania |
| --- | --- |

—

the acceding countries: Bulgaria and Romania

3.   Budget and project duration

The total budget earmarked for the cofinancing of projects is estimated at EUR 2,5 million.

In principle, Community financial support may not exceed 50 % of the amount of the eligible expenses for implementing the project. However, article 6(5) of Decision No 20/2004/EC allows a Community contribution of up to 75 % of the eligible expenses for implementing the project for certain projects and for the period 2004-2007 the Commission proposes to give priority to projects involving consumer organisations from the new Member States and acceding countries.

The duration of projects should not exceed 36 months.

4.   Deadline

Applications must be sent to the Commission no later than 30 June 2006.

5.   Further information

The full text of the call for proposals and the application forms are available on the following website:

http://europa.eu.int/comm/consumers/tenders/information/grants/projects_en.htm

Applications must comply with the requirements set out in the full text and be submitted using the form provided.

---

(1)  http://europa.eu.int/comm/consumers/overview/cons_policy/index_en.htm

---

| 28.4.2006 | EN | Official Journal of the European Union | C 102/15 |
| --- | --- | --- | --- |

28.4.2006

EN

Official Journal of the European Union

C 102/15

---

Second call for proposals for the community programme on the conservation, characterisation, collection and utilisation of genetic resources in agriculture established by Council Regulation (EC) No 870/2004 of 24 April 2004 (1)

Call identifier: AGRI GEN RES 2006

(2006/C 102/11)

1.   BACKGROUND

On 24 April 2004, the Council adopted Regulation (EC) No 870/2004 (1) on the conservation, characterisation, collection and utilisation of genetic resources in agriculture. The Regulation defines in Articles 5, 6 and 7 and Annex I the types of actions the Community may fund.

In accordance with Article 8(1) of that Regulation and after consultation of the Committee as laid down in Articles 8(1) and 15(2) of the Regulation, the Commission adopted, in December 2004, a work programme (2), setting out the objectives, the general provisions and the types of actions to be funded.

In accordance with Articles 9 and 15(2) of the Regulation, and after consultation of the Committee, the European Commission (referred to as ‘the Commission’) invites applications in the field of genetic resources in agriculture covering the actions concerned. The actions submitted under this call for proposals (referred to as ‘the Call’) could be funded from appropriations available in the 2006 budget.

2.   OBJECTIVES, SCOPE OF THE COMMUNITY PROGRAMME AND ELIGIBLE ACTIONS

2.1.   Objectives

The main objectives of the Community programme established under Council Regulation (EC) No 870/2004 are:

| — | to help ensure and improve the conservation, characterisation, collection and utilisation of genetic resources in agriculture in the Community; |
| --- | --- |

—

to help ensure and improve the conservation, characterisation, collection and utilisation of genetic resources in agriculture in the Community;

| — | to complement and promote at Community level the work undertaken in the Member States for the conservation, characterisation, collection, and utilisation of genetic resources in agriculture; |
| --- | --- |

—

to complement and promote at Community level the work undertaken in the Member States for the conservation, characterisation, collection, and utilisation of genetic resources in agriculture;

| — | to facilitate co-ordination in the field of international undertakings on genetic resources in agriculture. |
| --- | --- |

—

to facilitate co-ordination in the field of international undertakings on genetic resources in agriculture.

2.2.   Scope

As referred to in Article 2 and specified in Annex I of Council Regulation (EC) No 870/2004, the Community programme applies to plant, microbial and animal genetic resources which are or could be of use in agriculture and which currently occur within the territory of the Community.

2.3.   Actions

Under this Call, the Commission may finance three types of actions for the implementation of the Community programme:

| — | targeted actions aiming at the ex situ, in situ and on-farm conservation, characterisation, evaluation, collection, documentation, development and utilisation of genetic resources in agriculture; |
| --- | --- |

—

targeted actions aiming at the ex situ, in situ and on-farm conservation, characterisation, evaluation, collection, documentation, development and utilisation of genetic resources in agriculture;

| — | concerted actions aiming at improving the co-ordination at Community level, mainly through the organisation of seminars and the preparation of reports, of individual (national, regional, local) actions for the conservation, characterisation, evaluation, collection, documentation, development and utilisation of genetic resources in agriculture that are already being carried out in the Member States; |
| --- | --- |

—

concerted actions aiming at improving the co-ordination at Community level, mainly through the organisation of seminars and the preparation of reports, of individual (national, regional, local) actions for the conservation, characterisation, evaluation, collection, documentation, development and utilisation of genetic resources in agriculture that are already being carried out in the Member States;

| — | accompanying actions including information, dissemination and advisory actions. |
| --- | --- |

—

accompanying actions including information, dissemination and advisory actions.

The actions co-financed under the Community programme shall have a maximum duration of four years, as specified in Article 8(2) of Council Regulation (EC) No 870/2004.

3.   GENERAL INSTRUCTIONS FOR SUBMITTING PROPOSALS

3.1.   How to prepare a proposal

Before applying, proposers should carefully read this Call, Council Regulation (EC) No 870/2004, the work programme, the guide for proposers, especially the rules for participation, and all other relevant documentation available on the Commission's web site:

http://europa.eu.int/comm/agriculture/envir/biodiv/genres/call_en.htm

Proposers shall comply with the rules for participation specified in the guide for proposers and the conditions of this Call.

Proposers must prepare and submit:

| — | one paper copy of their full application accompanied by the supporting documents signed by the legally authorised representative of the proposer organisation or, in case of a natural person, by the proposer. These documents shall also include an application letter and the budget forms, which must also be signed by the above-mentioned legally authorised representative or proposer. Proposers should make certain that, in case of proposals with several partners, each partner signs the relevant forms also. |
| --- | --- |

—

one paper copy of their full application accompanied by the supporting documents signed by the legally authorised representative of the proposer organisation or, in case of a natural person, by the proposer. These documents shall also include an application letter and the budget forms, which must also be signed by the above-mentioned legally authorised representative or proposer. Proposers should make certain that, in case of proposals with several partners, each partner signs the relevant forms also.

| — | an electronic version of their application on CD ROM compatible with Windows XP (3). |
| --- | --- |

—

an electronic version of their application on CD ROM compatible with Windows XP (3).

Proposals must be submitted in an official language of the European Union. However, it is strongly recommended to prepare and submit the proposal in English to facilitate the evaluation by an international group of independent experts.

3.2.   When and to whom to send proposals

To be eligible, proposals consisting of the paper copy and the CD ROM must be sent by the proposer to the Commission not later than 30 June 2006 for targeted, concerted actions and accompanying actions.

The proposals must be sent by registered mail with acknowledgement of receipt (the postmark on the envelope being taken as proof of the date of sending) to the following address:

| European Commission |
| --- |
| DG AGRI |
| ‘AGRI RES GEN 2006’ |
| Att: Mr Leo Maier |
| Rue de Genève 1 |
| B-1049 Brussels |

European Commission

DG AGRI

‘AGRI RES GEN 2006’

Att: Mr Leo Maier

Rue de Genève 1

B-1049 Brussels

Proposals will be rejected if they are sent after the due date as specified above, or if they are sent to other postal addresses than the one specified above. Submissions by e-mail or by fax are not permitted.

Proposals sent by the above-mentioned deadline but not received by the Commission within 15 calendar days after the deadline, i.e., by 15 July 2006, will not be considered eligible. Mail shall be considered to have been received on the date on which it is formally registered by the Commission. It is the responsibility of the proposers to ensure that the necessary precautions are taken to respect this deadline.

Without prejudice to the provisions of Article 178 of the Financial Regulation's Implementing Rules, proposals that are submitted on paper only (i.e., without the CD ROM) or are incomplete will not be accepted in the framework of the present call for proposals.

In the case of successive submissions of the same proposal, the Commission will examine the latest version received before the due date as specified above.

3.3.   Procedure and timetable followed by the Commission in dealing with the proposals

The following evaluation process is implemented as stated in the guide for proposers.

The Commission will first check the proposals against the eligibility criteria as indicated in the guide for proposers and in the guide for evaluators.

The eligibility criteria concern the correct and complete submission of the proposal (such as receipt of the proposal by the Commission on or before the deadline specified in the Call and completeness of the supporting documentation). Furthermore, proposers who are in one of the situations referred to in Articles 93 and 94 of Council Regulation (EC, Euratom) No 1605/2002 (4) will be excluded.

The supporting documents that shall accompany the proposal, including the supporting documents related to compliance with Articles 93 and 94 of Council Regulation (EC, Euratom) No 1605/2002, are listed in Annex I to this Call.

Proposals for actions to be financed under the Community programme will be selected on the basis of independent expert assessment as referred to in Article 9(5) of Council Regulation (EC) No 870/2004.

The selection and award criteria that will be used for this assessment are provided in Annex II to this Call, in the guide for proposers and in the guide for evaluators.

It is expected to draw up the list of beneficiaries and the amounts of the grants awarded by the end of 2006.

If the requested grant is awarded, the beneficiary will be asked to sign a grant agreement with the Commission, denominated in euro and specifying the conditions and the level of financing.

The possible start-up date of the selected actions is early to mid-2007. The starting date of the action will be specified in the grant agreement.

If the requested grant is not awarded, the proposer will be informed in writing, giving the reasons for the rejection of the proposal.

4.   FINANCING

Eligible costs are defined in the guide for proposers and the grant agreement (Article 14 of the General Conditions). The Community contribution for targeted actions shall not exceed 50 % of the total eligible cost of the action. For concerted and accompanying actions, it shall not exceed 80 % of the total eligible cost of the action.

No prefinancing is provided for the actions being awarded a grant under this Call. Contributions in kind shall not constitute eligible costs.

Selecting a proposal does not commit the Commission to granting the full amount requested by the proposer. Under no circumstances will the grant exceed the amount requested

In the budget of 2006, EUR 3,82 million are foreseen for grants. An increase of up to EUR 2,0 million may be granted at a later stage by the budgetary authorities. The indicative share for the targeted, concerted actions and accompanying actions is:

| Type of action | Indicative EU contribution as % of available funds |
| --- | --- |
| Targeted action | 81 % |
| Concerted action | 10 % |
| Accompanying action | 9 % |

Type of action

Indicative EU contribution as % of available funds

Targeted action

81 %

Concerted action

10 %

Accompanying action

9 %

---

(1)  OJ L 162, 30.4.2004, p. 18.

(2)  Commission Decision C(2004) 5355 of 28.12.2004.

(3)  Applications for actions should be submitted in PDF (‘portable document format’, version 3 or higher with embedded fonts) or RTF (‘rich text format’).

(4)  OJ L 248, 16.9.2002, p. 1.

---

ANNEX I

DOCUMENTS REQUIRED FOR SUBMISSION OF A PROPOSAL

| (1) | For proposers: the application letter signed by the legally authorised representative of the proposer organisation or, in case of a natural person, by the proposer. |
| --- | --- |

(1)

For proposers: the application letter signed by the legally authorised representative of the proposer organisation or, in case of a natural person, by the proposer.

| (2) | For proposers and partners: duly filled in application forms (all forms and documents of Annexes 1, 2 and 3 of the guide for proposers). |
| --- | --- |

(2)

For proposers and partners: duly filled in application forms (all forms and documents of Annexes 1, 2 and 3 of the guide for proposers).

| (3) | For proposers and partners: the declarations of financial commitment have to be dated and signed by the legally authorised representative of the proposer/partner organisation or, in case of a natural person, by the proposer/partner as appropriate. |
| --- | --- |

(3)

For proposers and partners: the declarations of financial commitment have to be dated and signed by the legally authorised representative of the proposer/partner organisation or, in case of a natural person, by the proposer/partner as appropriate.

| (4) | For other providers of funds (excluding proposers and partners): proof of such contributions (which must consist at least of an official attestation of financing from each of the expected providers mentioning the title of the measure and the amount to be contributed). |
| --- | --- |

(4)

For other providers of funds (excluding proposers and partners): proof of such contributions (which must consist at least of an official attestation of financing from each of the expected providers mentioning the title of the measure and the amount to be contributed).

| (5) | For proposers: the completed and dated financial identification sheet and legal entity identification sheet that have to be signed by the legally authorised representative of the proposer organisation or, in case of a natural person, by the proposer and the partners, as appropriate. |
| --- | --- |

(5)

For proposers: the completed and dated financial identification sheet and legal entity identification sheet that have to be signed by the legally authorised representative of the proposer organisation or, in case of a natural person, by the proposer and the partners, as appropriate.

| (6) | For proposers and partners: a copy of the articles of association and the most recent general report, plus, where applicable, the organisation chart and the rules of procedure, if these are referred to in the articles of association. |
| --- | --- |

(6)

For proposers and partners: a copy of the articles of association and the most recent general report, plus, where applicable, the organisation chart and the rules of procedure, if these are referred to in the articles of association.

| (7) | For proposers (except public bodies): Declaration on honour signed and dated by the legally authorised representative of the proposer organisation or, in case of a natural person, by the proposer, drawn up in accordance with the model provided in the guide for proposers,






  (a) | stating that the proposer is not in one of the following situations:






  — | they are bankrupt or being wound up, are having their affairs administered by the courts, have entered into an arrangement with creditors, have suspended business activities, are the subject of proceedings concerning those matters, or are in any analogous situation arising from a similar procedure provided for in national legislation or regulations, |
| --- | --- | --- | --- |

(7)

For proposers (except public bodies): Declaration on honour signed and dated by the legally authorised representative of the proposer organisation or, in case of a natural person, by the proposer, drawn up in accordance with the model provided in the guide for proposers,

(a)

stating that the proposer is not in one of the following situations:

—

they are bankrupt or being wound up, are having their affairs administered by the courts, have entered into an arrangement with creditors, have suspended business activities, are the subject of proceedings concerning those matters, or are in any analogous situation arising from a similar procedure provided for in national legislation or regulations,

| — | they have been convicted of an offence concerning their professional conduct by a judgment which has the force of res judicata, |
| --- | --- |

—

they have been convicted of an offence concerning their professional conduct by a judgment which has the force of res judicata,

| — | they have been guilty of grave professional misconduct proven by any means which the contracting authority can justify, |
| --- | --- |

—

they have been guilty of grave professional misconduct proven by any means which the contracting authority can justify,

| — | they have not fulfilled obligations relating to the payment of social security contributions or the payment of taxes in accordance with the legal provisions of the country in which they are established or with those of the country of the contracting authority or those of the country where the contract is to be performed, |
| --- | --- |

—

they have not fulfilled obligations relating to the payment of social security contributions or the payment of taxes in accordance with the legal provisions of the country in which they are established or with those of the country of the contracting authority or those of the country where the contract is to be performed,

| — | they have been the subject of a judgment which has the force of res judicata for fraud, corruption, involvement in a criminal organisation or any other illegal activity detrimental to the Communities' financial interests, |
| --- | --- |

—

they have been the subject of a judgment which has the force of res judicata for fraud, corruption, involvement in a criminal organisation or any other illegal activity detrimental to the Communities' financial interests,

| — | following another procurement procedure or grant award procedure financed by the Community budget, they have been declared to be in serious breach of contract for failure to comply with their contractual obligations; |
| --- | --- |

—

following another procurement procedure or grant award procedure financed by the Community budget, they have been declared to be in serious breach of contract for failure to comply with their contractual obligations;

| (b) | stating that the proposer has paid its contributions to the social security body; |
| --- | --- |

(b)

stating that the proposer has paid its contributions to the social security body;

| (c) | stating that the proposer has paid his/her taxes and dues to the tax authorities in the country where the proposer is established; |
| --- | --- |

(c)

stating that the proposer has paid his/her taxes and dues to the tax authorities in the country where the proposer is established;

| (d) | stating that the proposer is not involved in proceedings relating to bankruptcy, judicial settlement, liquidation or composition with creditors. |
| --- | --- |

(d)

stating that the proposer is not involved in proceedings relating to bankruptcy, judicial settlement, liquidation or composition with creditors.

| (8) | For proposers (except public bodies): a recent excerpt of the proposer's enrolment in the professional register provided for under the legislation of the Member State in which they are established. |
| --- | --- |

(8)

For proposers (except public bodies): a recent excerpt of the proposer's enrolment in the professional register provided for under the legislation of the Member State in which they are established.

| (9) | For proposers and partners: dated and signed form relating to conflicts of interest drawn up in accordance with the model provided in the guide for proposers. |
| --- | --- |

(9)

For proposers and partners: dated and signed form relating to conflicts of interest drawn up in accordance with the model provided in the guide for proposers.

| (10) | For proposers (except public bodies) and partners (except public bodies): balance sheets and annual accounts for the last three financial years for which the accounts have been closed. |
| --- | --- |

(10)

For proposers (except public bodies) and partners (except public bodies): balance sheets and annual accounts for the last three financial years for which the accounts have been closed.

| (11) | For proposers (except public bodies) requesting a grant equal or higher than EUR 300 000: an external audit report, produced by an approved auditor, certifying the accounts for the last closed financial year and giving an assessment of the financial viability of the proposer. |
| --- | --- |

(11)

For proposers (except public bodies) requesting a grant equal or higher than EUR 300 000: an external audit report, produced by an approved auditor, certifying the accounts for the last closed financial year and giving an assessment of the financial viability of the proposer.

| (12) | For proposers and partners: curriculum vitae of the staff who will carry out the proposed action. |
| --- | --- |

(12)

For proposers and partners: curriculum vitae of the staff who will carry out the proposed action.

| (13) | For proposers and partners: references relating to any other actions completed in the relevant field. |
| --- | --- |

(13)

For proposers and partners: references relating to any other actions completed in the relevant field.

---

ANNEX II

1.   Selection criteria:

| — | Technical capacity:
  Proposers and partners must demonstrate that:






  — | they have the necessary technical skills of direct relevance to the action proposed; |
| --- | --- | --- |

—

Technical capacity:

Proposers and partners must demonstrate that:

—

they have the necessary technical skills of direct relevance to the action proposed;

| — | they have at least three years experience in dealing with the subject(s) proposed. |
| --- | --- |

—

they have at least three years experience in dealing with the subject(s) proposed.

| — | Financial capacity:
  Proposers and partners must demonstrate that:






  — | they have the adequate solvency, based on the last three closed balance sheets/annual accounts, to maintain their activity throughout the period during which the measure is being carried out and to participate in its funding. |
| --- | --- | --- |

—

Financial capacity:

Proposers and partners must demonstrate that:

—

they have the adequate solvency, based on the last three closed balance sheets/annual accounts, to maintain their activity throughout the period during which the measure is being carried out and to participate in its funding.

| — | Compliance with the scope of the Community programme, as referred to in Article 2 of Council Regulation (EC) No 870/2004. |
| --- | --- |

—

Compliance with the scope of the Community programme, as referred to in Article 2 of Council Regulation (EC) No 870/2004.

| — | As specified in Annex I of Council Regulation (EC) No 870/2004, the genetic resources concerned by the proposal currently occur within the territory of the Community. |
| --- | --- |

—

As specified in Annex I of Council Regulation (EC) No 870/2004, the genetic resources concerned by the proposal currently occur within the territory of the Community.

2.   Award criteria:

Eligible proposals will be evaluated in the light of the following criteria:

| 1. | Relevance of the action to the objectives of the Community programme; |
| --- | --- |

1.

Relevance of the action to the objectives of the Community programme;

| 2. | Technical quality of the proposed work; |
| --- | --- |

2.

Technical quality of the proposed work;

| 3. | Quality of the management of the action; |
| --- | --- |

3.

Quality of the management of the action;

| 4. | European added value and potential impact of the action; |
| --- | --- |

4.

European added value and potential impact of the action;

| 5. | Quality of the coordination between the proposer and the partners; |
| --- | --- |

5.

Quality of the coordination between the proposer and the partners;

| 6. | Mobilisation of resources for the action. |
| --- | --- |

6.

Mobilisation of resources for the action.

---